reSee.it - Related Video Feed

In a Phase one trial, a normal volunteer tests the safety of a potential vaccine. This process has been completed at a record speed. However, it will still take a few months to confirm its initial safety. The next step is a Phase two trial, involving hundreds or even thousands of people, which will take an additional 6 to 8 months to determine if the vaccine is effective. Overall, it will take around a year to a year and a half to know if the vaccine can be used. Another important aspect is ensuring that the vaccine does not worsen the infection. This can only be determined through extended studies involving individuals at risk. Previous cases have shown that vaccines that initially appeared safe actually made the situation worse. Therefore, caution is necessary before administering the vaccine.

We have administered this type of vaccine to over one billion people, demonstrating its safety. While there is a very low risk of myocarditis, particularly in young men, the risk of developing myocarditis from COVID-19 is actually higher than from the vaccine.

According to our data from the CDC today, vaccinated people do not carry the virus and do not get sick. This finding is not limited to clinical trials; it is also supported by real-world data.

There is a new mRNA COVID-19 vaccine, but there is no evidence to support its effectiveness or safety in human trials. Additionally, several studies from different countries suggest that these vaccines may actually increase the risk of contracting COVID-19 over time. This is concerning and not a typical outcome.

The Oxford AstraZeneca vaccine is safe and recommended by regulators. Over 11 million people have been vaccinated, showing it is safe and saving lives. It is important to get the jab when you have the chance to stay safe.

Pfizer imported its own batch of vaccine for the employee vaccination program, which was not tested by the TGA.

This vaccine has been widely used and is considered safe, with experience in over a billion people. While there is a very low risk of myocarditis, especially in young men, associated with the mRNA technology, the risk of getting myocarditis from COVID-19 itself is higher than the risk from the vaccine.

The COVID-19 vaccines have proven to be highly effective in the real world. Both the mRNA vaccine and another vaccine have shown efficacy rates of 94% to 95% for mild to moderate disease. In fact, the real world effectiveness of these vaccines is even more impressive than the results of the clinical trials. It is clear that these vaccines are highly effective in preventing COVID-19.

Data from the CDC suggests vaccinated people do not carry the virus or get sick. This observation is based not only on clinical trials but also on real-world evidence.

We have experience with this vaccine in a billion people, showing it is safe. The mRNA vaccine carries a very low risk of myocarditis, especially in young men. However, the risk of myocarditis from COVID is higher than from the vaccine.

There have been no concerning long-term side effects of the vaccine so far. The vaccine has only been in use for about a year, and we haven't seen any alarming issues with other vaccines that have been used for a long time. While we can't say for certain what might happen after several years, there is no scientific reason to believe that problems would suddenly arise. Although the vaccine is new, we have no plausible reason to expect any issues in the future.

Safe and effective vaccines have been developed and millions of doses are being delivered. The vaccines have been rigorously studied and proven to be safe and effective. Researchers have confirmed the safety and efficacy of various vaccines, including the Oxford AstraZeneca and Pfizer COVID-19 vaccines. Vaccination has been deemed safe and effective for children, with Pfizer's vaccine being 100% effective for kids aged 5 to 11. The European Medicines Agency has thoroughly assessed the vaccines and concluded they are safe and effective against COVID-19. The vaccines have undergone extensive testing and have been found to be extremely safe and effective. Overall, vaccines are considered safe, effective, and free.

We have tested the vaccine on billions of people worldwide.

There is confidence in the AstraZeneca vaccine, and there is no evidence that it causes blood clots. The TGA is closely monitoring the situation and released a statement saying that they do not see any link between the vaccine and blood clots. The TGA, ATAGI, and the speaker are in unanimous agreement that there is no link between AstraZeneca and blood clots. The World Health Organization also addressed the issue.

Developing a safe and effective vaccine typically takes 10 to 25 years, with the fastest in the US being around 3 to 4 years. The timeline for COVID-19 vaccines is similar to other vaccines, with some minor differences. This should reassure those hesitant about getting vaccinated.

The speaker expresses concern that only 5% of adverse reactions are reported in the database, suggesting it's just the tip of the iceberg. Another speaker reassures that the vaccine is safe and there is no evidence of it causing deaths. Prior to the COVID vaccine rollout, an average of 1500 adverse event reports were received annually for all vaccines in New Zealand, resulting in one or fewer reported deaths per year.

Medsafe has approved the Pfizer BioNTech COVID-19 vaccine for use in New Zealand. This provisional approval was agreed to and gazetted today by Medsafe. This marks the start of a new chapter in New Zealand's COVID-19 response and is a significant milestone. The most important things under consideration have been the safety, effectiveness, and quality of production of the vaccine. Medsafe's assessment process is extremely robust. Medsafe has completed its work with its advisory committee, looking at the data from clinical trials to advise on using the Pfizer vaccine in New Zealand. Even as the vaccine is rolled out, New Zealand's elimination strategy is still the way the country is dealing with the virus. Medsafe's process is meant to reassure New Zealanders that this vaccine and others that come after it are safe, effective, and the right thing to use in New Zealand.

We have experience with this vaccine in a billion people, showing it is safe. While there is a low risk of myocarditis with mRNA vaccines, the risk from COVID is higher than the vaccine's risk, especially in young men.

This vaccine has been widely used and proven safe in billions of people. The risk of myocarditis, especially in young men, is very low.

According to the latest CDC data, vaccinated individuals do not carry the virus or get sick. This observation isn't limited to clinical trials but extends to real-world scenarios as well.

According to the CDC, vaccinated individuals do not carry or get sick from the virus, as supported by both clinical trials and real-world data.

Pfizer's claim of 96% efficacy for their vaccine was questioned. The study and data were not independently verified, and Pfizer wanted to keep the data hidden for 75 years. The true effectiveness of the vaccine, based on absolute risk reduction, is less than 1%. More people died and were harmed in their trials compared to the placebo group. The vaccine's safety was questionable from the start, and it is not effective. Additionally, appropriate studies were not conducted for new variants.

We are preparing for a complex vaccination program in Canada. We expect a favorable decision soon for the approval of the Pfizer vaccine and others. However, we are still waiting for key information regarding the manufacturing process. Health Canada has authorized the first COVID-19 vaccine in Canada after a thorough assessment of the evidence. It was authorized under the Canadian Interim Order pathway, which allows for flexibility in the review process. Canadians can have confidence in our rigorous review process. If it is their turn to get the vaccine, they should feel comfortable getting it. We have always emphasized that even the best vaccine is only effective if people get vaccinated.

Pfizer imported their own batch of vaccine specifically for the employee vaccination program, which was not tested by the TGA.

None of the vaccines, including the COVID vaccine, have undergone proper testing. No childhood vaccine has completed a placebo-controlled clinical trial with sufficient duration and power to confirm its safety before being administered to millions of children in America. This is not an opinion; it can be verified by anyone visiting the FDA website, where the package inserts and clinical trial documents are available for review.